Caitlyn L Miller

5PUBLICATIONS
16CO-AUTHORS
Medical devicesSolid tumoursMolecular targetsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 03, 2023
Design of a mucin-selective protease for targeted degradation of cancer-associated mucins.

Kayvon Pedram, D Judy Shon, Gabrielle S Tender

|May 31, 2023
Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors.

Caitlyn L Miller, Idit Sagiv-Barfi, Patrick Neuhöfer

|Jun 08, 2021
Targeting the tetraspanin CD81 reduces cancer invasion and metastasis.

Felipe Vences-Catalán, Ranjani Rajapaksa, Chiung-Chi Kuo

|Mar 26, 2021
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.

Green Ahn, Steven M Banik, Caitlyn L Miller

|Aug 19, 2020
Targeted glycan degradation potentiates the anticancer immune response in vivo.

Melissa A Gray, Michal A Stanczak, Natália R Mantuano

Pageof 1